John Butler

Dr John Butler is a Research Fellow in Glycoprotein Therapeutics at the University of Southampton, specializing in molecular mechanisms of protein trafficking and viral glycoprotein interactions. His work bridges structural biology and virology with significant contributions to understanding SARS-CoV-2 spike dynamics and cellular transport systems.

His primary research focuses on glycoprotein therapeutics and ER-Golgi intermediate compartment dynamics, examining how viral pathogens like SARS-CoV-2 manipulate host glycosylation machinery. Early career work established foundational knowledge of SERCA1 calcium pump regulation and phospholamban/sarcolipin trafficking mechanisms, while recent publications demonstrate a strategic pivot toward viral pathogenesis and therapeutic interventions.

Analysis of his publication trajectory reveals an evolution from fundamental cellular trafficking studies (2003-2015) toward contemporary virology applications (2021-2023), particularly in characterizing the SARS-CoV-2 glycan shield's role in viral infectivity and antibody evasion. His collaborative work spans structural biology, respiratory medicine, and immunology.

Dr Butler actively contributes to the Molecular and Precision Biosciences research group, utilizing advanced techniques in molecular modeling, protein biochemistry, and cellular imaging. His current work integrates computational and experimental approaches to develop glycoprotein-based therapeutic strategies against emerging viral threats.